🦊/Companies

Rho Bio

1 known investors

Find your way into Rho Bio

710 people in our graph share verified history with the Rho Bio team — schools, employers, funds. One of them is your warm intro.

Akshat Goenkaunlockedknows Jennifer Beecham · together at University of Pennsylvania (overlapped)
×4knows the team · via University of Pennsylvania
×5knows the team · via Barclays
knows the team · via The Johns Hopkins University
knows the team · via Yale School of Medicine

Rho Bio is a biotechnology company focused on lymphatic flow, developing therapeutics related to the lymphatic system.

Founders & leadership

JBJennifer Beecham
Jennifer BeechaminPresident, Co-FounderJennifer Beecham is co-founder and president of Rho Bio, a biotechnology company developing therapeutics for the lymphatic system. She previously held finance, strategy, and commercial roles at Reata Pharmaceuticals and worked in algorithmic trading at Barclays, and holds a Master's degree in Bioengineering with four years of radiation oncology research experience.
ESEric Song
Eric SonginScientific FounderHis research background centers on immune mechanisms in the brain and eye.
AR
Aaron RingScientific Founder
JK
Jonathan KipnisScientific Founder
AI
Akiko IwasakiScientific Founder

Investors · 1

Competitors · 4

by search overlap

Companies competing with Rho Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Rho Bio do?
Rho Bio is a biotechnology company focused on lymphatic flow, developing therapeutics related to the lymphatic system.
Who founded Rho Bio?
Rho Bio was founded by Jennifer Beecham, Eric Song, Aaron Ring, Jonathan Kipnis, Akiko Iwasaki.
Who are Rho Bio's investors?
Rho Bio's investors include Connecticut Innovations.